Taiwan's healthcare system is taking a leaf out of the UK's book, with the National Health Insurance Administration (NHIA) renewing its partnership with the British National Institute for Health and Care Excellence (NICE). This collaboration, which has already borne fruit, is set to further enhance Taiwan's healthcare infrastructure and patient access to innovative treatments.
The partnership, which was first signed in 2023, focuses on three key areas: innovative healthcare assessment frameworks, digital transformation, and HTA talent development. By working together, the two organizations aim to improve HTA and reimbursement systems for high-cost emerging technologies, such as gene and cell therapies. This will not only benefit patients by expanding access to new therapies but also ensure the sustainability of the National Health Insurance system.
In the realm of digital transformation, the partnership will facilitate the sharing of experiences in digital governance for cancer care. This includes the promotion of fast healthcare interoperability resources, an international standard for healthcare data exchanges. By advancing digital transformation in healthcare data, the partnership could streamline prior authorization processes and establish real-world evaluation systems for cancer treatment outcomes.
The partnership will also cultivate more HTA talent through training programs, expert exchanges, and information-sharing networks. This will improve policymaking by incorporating healthcare, long-term care, and social care needs into the policy evaluation process and integrating related resources. By doing so, the partnership will ensure that Taiwan's healthcare policies are comprehensive and responsive to the needs of its citizens.
One of the most significant benefits of this partnership is the introduction of a provisional payment system inspired by the UK's Cancer Drugs Fund. This system aims to expand patient access to new therapies while maintaining the sustainability of the National Health Insurance system. By doing so, Taiwan is setting an example for other countries struggling with the high costs of new medical technologies.
In conclusion, the renewal of the partnership between the NHIA and NICE is a significant step forward for Taiwan's healthcare system. By focusing on innovative assessment frameworks, digital transformation, and HTA talent development, the partnership will enhance patient access to innovative treatments and ensure the sustainability of the National Health Insurance system. As Taiwan continues to innovate in healthcare, it is setting an example for other countries to follow.
